# Spironolactone in the Treatment of Heart Failure

Study · id `cardio:ct-nct04727073` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04727073](<https://clinicaltrials.gov/study/NCT04727073>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04727073

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 743 participants.

## Technical summary

Registry record NCT04727073. Randomized; double masking; primary purpose treatment. Start 2018-11-01 (actual); primary completion 2024-10-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 743 participants (enrolled count; ClinicalTrials.gov record NCT04727073, source copy `cardio:ctgov-nct04727073-2025-03-28`, retrieved 2026-10-26)
- Started: 2018-11-01 (actual) (ClinicalTrials.gov record NCT04727073, source copy `cardio:ctgov-nct04727073-2025-03-28`, retrieved 2026-10-26)
- Primary completion: 2024-10-01 (actual) (ClinicalTrials.gov record NCT04727073, source copy `cardio:ctgov-nct04727073-2025-03-28`, retrieved 2026-10-26)
- Completion: 2024-10-01 (actual) (ClinicalTrials.gov record NCT04727073, source copy `cardio:ctgov-nct04727073-2025-03-28`, retrieved 2026-10-26)
- Countries: Austria; France; Germany; Netherlands; Serbia (ClinicalTrials.gov record NCT04727073, source copy `cardio:ctgov-nct04727073-2025-03-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04727073-2025-03-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Spironolactone in the Treatment of Heart Failure
- Acronym: SPIRIT-HF
- Condition: Heart Failure with Mid-range Ejection Fraction
- Condition: Heart Failure with Preserved Ejection Fraction
- Intervention (Drug): Experimental: Spironolactone
- Intervention (Drug): Placebo Comparator
- Lead sponsor: Charite University, Berlin, Germany
- Lead sponsor class: OTHER
- Collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator class: OTHER
- Collaborator: Echo Core Lab Berlin
- Collaborator class: UNKNOWN
- Collaborator: University of Göttingen
- Collaborator class: OTHER
- Collaborator: University Medicine Greifswald
- Collaborator class: OTHER
- Collaborator: Ludwig-Maximilians - University of Munich
- Collaborator class: OTHER
- Collaborator: Institute for Cardiovascular Computer-assisted Medicine, Charité
- Collaborator class: UNKNOWN
- Collaborator: Coordinating Centre for Clinical Trials, Charité
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry lists this organization as the lead sponsor: Charite University, Berlin, Germany (`cardio:org-charite-university-berlin-germany`)
- Registry lists this organization as a collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (`cardio:org-deutsches-zentrum-fur-herz-kreislauf-forschung-dzhk`)
- Registry lists this organization as a collaborator: Ludwig-Maximilians - University of Munich (`cardio:org-ludwig-maximilians-university-of-munich`)

## Provenance

Content hash: e223626ebc4b3fe2a5249367854994ef59b9d40a309e3a9a735af431ce089416
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
